STEVANATO GROUP SPA (STVN) Stock Fundamental Analysis
USA - NYSE:STVN - IT0005452658 - Common Stock
27.23 USD
+1 (+3.81%)
27.23 USD
0 (0%)
Taking everything into account, STVN scores 4 out of 10 in our fundamental rating. STVN was compared to 55 industry peers in the Life Sciences Tools & Services industry. STVN has only an average score on both its financial health and profitability. While showing a medium growth rate, STVN is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year STVN was profitable.
In the past year STVN had a positive cash flow from operations.
Each year in the past 5 years STVN has been profitable.
In the past 5 years STVN always reported a positive cash flow from operatings.
1.2 Ratios
STVN has a Return On Assets of 5.72%. This is in the better half of the industry: STVN outperforms 80.00% of its industry peers.
With a decent Return On Equity value of 9.63%, STVN is doing good in the industry, outperforming 78.18% of the companies in the same industry.
STVN's Return On Invested Capital of 7.90% is fine compared to the rest of the industry. STVN outperforms 80.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for STVN is significantly below the industry average of 15.96%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.72% | ||
| ROE | 9.63% | ||
| ROIC | 7.9% |
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
1.3 Margins
STVN's Profit Margin of 11.75% is fine compared to the rest of the industry. STVN outperforms 78.18% of its industry peers.
In the last couple of years the Profit Margin of STVN has grown nicely.
STVN has a better Operating Margin (17.17%) than 80.00% of its industry peers.
In the last couple of years the Operating Margin of STVN has grown nicely.
The Gross Margin of STVN (28.83%) is worse than 74.55% of its industry peers.
In the last couple of years the Gross Margin of STVN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.17% | ||
| PM (TTM) | 11.75% | ||
| GM | 28.83% |
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
2. Health
2.1 Basic Checks
STVN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for STVN has been increased compared to 1 year ago.
STVN has less shares outstanding than it did 5 years ago.
STVN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.74 indicates that STVN is not in any danger for bankruptcy at the moment.
STVN has a Altman-Z score of 5.74. This is amongst the best in the industry. STVN outperforms 87.27% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that STVN is not too dependend on debt financing.
STVN has a Debt to Equity ratio (0.24) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.74 |
ROIC/WACC0.92
WACC8.56%
2.3 Liquidity
STVN has a Current Ratio of 1.79. This is a normal value and indicates that STVN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.79, STVN is doing worse than 61.82% of the companies in the same industry.
A Quick Ratio of 1.22 indicates that STVN should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.22, STVN is not doing good in the industry: 78.18% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.22 |
3. Growth
3.1 Past
STVN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.00%.
Measured over the past years, STVN shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.29% on average per year.
The Revenue has been growing slightly by 5.28% in the past year.
Measured over the past years, STVN shows a quite strong growth in Revenue. The Revenue has been growing by 15.53% on average per year.
EPS 1Y (TTM)4%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%22.22%
Revenue 1Y (TTM)5.28%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%7.86%
3.2 Future
STVN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.64% yearly.
Based on estimates for the next years, STVN will show a small growth in Revenue. The Revenue will grow by 7.98% on average per year.
EPS Next Y11.33%
EPS Next 2Y17.57%
EPS Next 3Y19.74%
EPS Next 5Y17.64%
Revenue Next Year6.98%
Revenue Next 2Y8.54%
Revenue Next 3Y9.28%
Revenue Next 5Y7.98%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 44.64, STVN can be considered very expensive at the moment.
STVN's Price/Earnings ratio is in line with the industry average.
STVN is valuated expensively when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
STVN is valuated quite expensively with a Price/Forward Earnings ratio of 34.76.
The rest of the industry has a similar Price/Forward Earnings ratio as STVN.
STVN is valuated expensively when we compare the Price/Forward Earnings ratio to 22.71, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.64 | ||
| Fwd PE | 34.76 |
4.2 Price Multiples
67.27% of the companies in the same industry are more expensive than STVN, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 23.93 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of STVN may justify a higher PE ratio.
A more expensive valuation may be justified as STVN's earnings are expected to grow with 19.74% in the coming years.
PEG (NY)3.94
PEG (5Y)1.64
EPS Next 2Y17.57%
EPS Next 3Y19.74%
5. Dividend
5.1 Amount
STVN has a yearly dividend return of 0.23%, which is pretty low.
STVN's Dividend Yield is rather good when compared to the industry average which is at 1.09. STVN pays more dividend than 83.64% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, STVN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.23% |
5.2 History
STVN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
10.74% of the earnings are spent on dividend by STVN. This is a low number and sustainable payout ratio.
DP10.74%
EPS Next 2Y17.57%
EPS Next 3Y19.74%
27.23
+1 (+3.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners112.76%
Inst Owner Change-3.52%
Ins Owners1.61%
Ins Owner ChangeN/A
Market Cap7.43B
Analysts83.53
Price Target29.69 (9.03%)
Short Float %4.24%
Short Ratio5.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.23% |
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP10.74%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.49%
Min EPS beat(2)2.71%
Max EPS beat(2)10.28%
EPS beat(4)3
Avg EPS beat(4)1.61%
Min EPS beat(4)-7.68%
Max EPS beat(4)10.28%
EPS beat(8)3
Avg EPS beat(8)-5.73%
EPS beat(12)6
Avg EPS beat(12)-2.97%
EPS beat(16)10
Avg EPS beat(16)0.11%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)1.72%
Max Revenue beat(2)2.33%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)2.33%
Revenue beat(8)3
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.39%
Revenue beat(16)7
Avg Revenue beat(16)-0.02%
PT rev (1m)2.86%
PT rev (3m)6.26%
EPS NQ rev (1m)-1.24%
EPS NQ rev (3m)-12.78%
EPS NY rev (1m)-0.98%
EPS NY rev (3m)-0.61%
Revenue NQ rev (1m)-0.39%
Revenue NQ rev (3m)-3.51%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.64 | ||
| Fwd PE | 34.76 | ||
| P/S | 5.5 | ||
| P/FCF | N/A | ||
| P/OCF | 30.47 | ||
| P/B | 4.5 | ||
| P/tB | 4.79 | ||
| EV/EBITDA | 23.93 |
EPS(TTM)0.61
EY2.24%
EPS(NY)0.78
Fwd EY2.88%
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)0.89
OCFY3.28%
SpS4.95
BVpS6.05
TBVpS5.69
PEG (NY)3.94
PEG (5Y)1.64
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.72% | ||
| ROE | 9.63% | ||
| ROCE | 10.51% | ||
| ROIC | 7.9% | ||
| ROICexc | 8.32% | ||
| ROICexgc | 8.73% | ||
| OM | 17.17% | ||
| PM (TTM) | 11.75% | ||
| GM | 28.83% | ||
| FCFM | N/A |
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
ROICexc(3y)11.09%
ROICexc(5y)13.59%
ROICexgc(3y)11.88%
ROICexgc(5y)15.21%
ROCE(3y)13.31%
ROCE(5y)14.16%
ROICexcg growth 3Y-28.59%
ROICexcg growth 5Y-6.94%
ROICexc growth 3Y-26.56%
ROICexc growth 5Y-4.42%
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
F-Score5
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.24 | ||
| Cap/Depr | 338.93% | ||
| Cap/Sales | 23.63% | ||
| Interest Coverage | 22.83 | ||
| Cash Conversion | 74.71% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.22 | ||
| Altman-Z | 5.74 |
F-Score5
WACC8.56%
ROIC/WACC0.92
Cap/Depr(3y)442.35%
Cap/Depr(5y)341.04%
Cap/Sales(3y)31.28%
Cap/Sales(5y)24.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%22.22%
EPS Next Y11.33%
EPS Next 2Y17.57%
EPS Next 3Y19.74%
EPS Next 5Y17.64%
Revenue 1Y (TTM)5.28%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%7.86%
Revenue Next Year6.98%
Revenue Next 2Y8.54%
Revenue Next 3Y9.28%
Revenue Next 5Y7.98%
EBIT growth 1Y6.16%
EBIT growth 3Y3.61%
EBIT growth 5Y23.8%
EBIT Next Year70.56%
EBIT Next 3Y33.35%
EBIT Next 5Y23.8%
FCF growth 1Y70.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.91%
OCF growth 3Y5.33%
OCF growth 5Y29.6%